Ally Bridge Group (Ny) LLC Praxis Precision Medicines, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $141 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding PRAX
# of Institutions
1Shares Held
75KCall Options Held
0Put Options Held
0About Praxis Precision Medicines, Inc.
- Ticker PRAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,576,100
- Market Cap $3.35B
- Description
- Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...